Olmesartan medoxomil: a review of its use in the management of hypertension.
about
Severe spruelike enteropathy associated with olmesartanManagement of Hypertension Using Olmesartan Alone or in CombinationHuman carboxymethylenebutenolidase as a bioactivating hydrolase of olmesartan medoxomil in liver and intestine.WIN OVER study: Efficacy and safety of olmesartan in Indian hypertensive patients: results of an open label, non-comparative, multi-centric, post marketing observational studyAntihypertensive effects of olmesartan compared with other angiotensin receptor blockers: a meta-analysis.Olmesartan medoxomil for the treatment of hypertension in children and adolescentsThe comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases.Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.Clinical-Pathological Conference Series from the Medical University of Graz: Case No 156: 82-year-old woman with chronic diarrhea and weight loss of 20 kilogramsThe fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertensionLosartan chemistry and its effects via AT1 mechanisms in the kidneyIssues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers.Olmesartan medoxomil/amlodipine/hydrochlorothiazide: fixed-dose combination in hypertension.Olmesartan/amlodipine: a review of its use in the management of hypertension.Fixed-combination therapy to improve blood pressure control: experience with olmesartan-based therapy.Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy.Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension.A review of the use of angiotensin receptor blockers for the prevention of cardiovascular events in patients with essential hypertension without compelling indications.Effectiveness of the fixed-dose combination of olmesartan/amlodipine/hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD.Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence.Transdermal delivery of angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs) and others for management of hypertension.Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension.Synthesis and Physicochemical Characterization of the Process-Related Impurities of Olmesartan Medoxomil. Do 5-(Biphenyl-2-yl)-1-triphenylmethyltetrazole Intermediates in Sartan Syntheses Exist?Olmesartan-associated enteropathy: new insights on the natural history? Report of two cases.Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment.Is the reno-protective effect of valsartan dose dependent? A comparative study of 80 and 160 mg day(-1).Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method.Olmesartan-induced enteropathy.Antihypertensive Efficacy and Safety of Olmesartan Medoxomil and Ramipril in Elderly Mild to Moderate Essential Hypertensive Patients With or Without Metabolic SyndromeAntihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension
P2860
Q28269450-8B56FCB3-5D01-4B04-A68B-79F612630C5EQ33734043-8DF27BEE-EEC4-4273-8CB1-C62180328724Q33782444-88FE268E-6430-479D-9AE1-5E7A88B5059BQ34002218-D6D93C83-F55A-4732-B9AC-7762CBD7D3E2Q34392647-27EE6AC3-1525-44D3-9EB6-F9DDE99B0326Q34772915-5EEA5BAB-C34E-4F83-8EA7-E9059400321EQ35001942-3EB2A198-8C3B-4AC3-A7A5-338491090C3DQ35085669-50621A9B-D8A6-47E4-9DBA-3CDE5453F92BQ36371687-285821B3-8153-4732-ADED-A08B53F53C83Q37502956-E511AAF7-BFEA-488C-9E0D-50F190E2D9A7Q37595616-057F9C95-0004-49A4-9895-6FE73126697BQ37679899-50CDB1F1-E13D-4AAB-BB9C-E334C5FCF929Q37833062-9430B698-7D44-4CDE-BAD6-A81756FAFB8DQ37864949-D051ADDB-1BD7-41C3-8DB8-C6238EB0A048Q37910206-F3FA8496-02D4-4EC1-93E7-4644178FB84BQ38061463-793F9C59-C745-4399-B2CC-C93DEF2DFAD0Q38079623-B708B484-14A4-4A1F-803F-4FB9149C970AQ38098985-7E9CDE4A-1092-4BD4-BBE0-62B371A65611Q38145263-AB45CF89-489B-4DE7-94B0-AE1EAD0FED67Q38156340-0773F355-A408-416E-AB71-4AF1EB13BB02Q38234364-8A63CEA0-CBB1-4BCA-B68D-BEDF7F5CC948Q39479847-6CAB934A-370C-45BB-8794-EC02E690EAEFQ40245850-901054D2-BB73-4F32-9ACE-51A9B2D5DCC3Q41042155-3358B3FF-BDD4-46C8-8114-3ACC64A6D2BEQ42688526-B4EB456A-DA58-42C5-8EE7-B37FCB9F4AAEQ42697711-14690621-A0E4-4EA2-82AE-4655114A2AD4Q43016390-9C501E9D-80DF-4FB6-9CDE-30F8834CF4B9Q43274970-7D6F06EC-2815-4D26-A92D-2717BDC12D10Q53645573-3983C436-36C7-44A8-A2F8-F73F7B255977Q57490130-5AB7A467-E89D-426C-97D9-493AF8B823B8Q57490186-AEDDC5A3-CD78-4A3B-841E-0FC1383A478D
P2860
Olmesartan medoxomil: a review of its use in the management of hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Olmesartan medoxomil: a review of its use in the management of hypertension.
@en
Olmesartan medoxomil: a review of its use in the management of hypertension.
@nl
type
label
Olmesartan medoxomil: a review of its use in the management of hypertension.
@en
Olmesartan medoxomil: a review of its use in the management of hypertension.
@nl
prefLabel
Olmesartan medoxomil: a review of its use in the management of hypertension.
@en
Olmesartan medoxomil: a review of its use in the management of hypertension.
@nl
P1433
P1476
Olmesartan medoxomil: a review of its use in the management of hypertension.
@en
P2093
Paul L McCormack
P304
P356
10.2165/00003495-200868090-00005
P577
2008-01-01T00:00:00Z
P6179
1014700514